Researchers identify protein patterns linked to chemotherapy resistance in bladder cancer

President Donald Trump has introduced a new effort to help Americans more easily share their health records with doctors, using new technology and artificial intelligence (AI) tools.

The earliest warning signs of multiple sclerosis (MS) may emerge more than a decade before the first classical neurological symptoms occur, according to new research from the University of British Columbia.

A paper published in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel synthetic ligand that activates the Notch signaling pathway, a key driver in T-cell development and function.

Medicare drug plans are increasingly excluding coverage of new specialty drugs that treat complex conditions like cancers and autoimmune diseases. New research from the USC Schaeffer Center shows how these barriers may come at a cost to patients' health.

A sudden surge of chikungunya cases has been reported in Foshan city in China, increasing from 478 cases to almost 3,000 cases within a week, according to South China Morning Post.

Less radiation exposure during diagnosis and treatment for breast and lung cancer: new Fraunhofer method combines X-ray imaging and radar.

A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the current gold standard. This research, published in the July issue of The Journal of Nuclear Medicine, lays the foundation for further development of radionuclide therapies targeting CSCs, offering renewed hope for more effective treatment options and improved outcomes for patients.

A new Stanford-led study sheds light on "an emerging psychological health crisis" that disproportionately affects girls. Published July 30 in The Lancet Planetary Health, the study is among the first to quantify how repeated climate stressors impact the psychological well-being and future outlook of adolescents in low-resource settings.

Intestinal bacteria are important for human health as they help digest food and regulate immune function. Thus, in recent years, it has become clear that gut microbiota dysbiosis, an imbalance in types and composition of intestinal bacteria, is associated with digestive disorders and other diseases. However, the mechanism by which bacteria interact in the intestine to maintain the microbiota balance remains unclear.

Males born in summer months reported higher depression symptom scores than males born during other seasons, according to a study from Kwantlen Polytechnic University. Anxiety symptoms showed no association with season of birth for either sex.

It's a cold, crisp evening and the air carries a chill that bites. As temperatures drop and houses get colder, we turn to trusted sources of warmth such as wood fires, heaters, hot water bottles and warm drinks.

Without even realizing it, your world sometimes gradually gets smaller: less walking, fewer days in the office, canceling on friends. Watching plans disintegrate on the chat as friends struggle to settle on a date or place for a catch-up.

Heart attacks remain a leading cause of death and disability worldwide. The permanent loss of heart muscle cells—known as cardiomyocytes—and the heart's limited regenerative capacity often lead to chronic heart failure. Current treatment strategies manage symptoms but do not repair the underlying damage.

In a first-of-its-kind clinical trial, UCLA scientists have shown it's possible to reprogram a patient's blood-forming stem cells to generate a continuous supply of functional T cells, the immune system's most powerful cancer-killing agents. This approach suggests a new way to deliver immunotherapy, acting as an internal factory that produces tumor-targeting immune cells over time and potentially offering longer-lasting protection.

Mayo Clinic has treated the first person in the U.S. using a novel radioactive medicine for advanced breast cancer as part of an international multisite clinical trial.

Biomedical and genetic engineers at Duke University and the Albert Einstein College of Medicine have developed a technique that naturally increases the presence of a light-sensitive molecule throughout the body. This change makes it possible to both improve deep tissue imaging in areas like the brain and expand the capabilities of light-based tools to control cellular behavior.

Researchers at The City College of New York have linked chemotherapy treatment to lasting cognitive changes in rats—potentially shedding light, for the first time, on cognitive problems some cancer survivors experience long after treatment ends.

A research team led by Prof. Li Hai from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has developed a multimodal deep-learning model for predicting the malignancy of TI-RADS 4 thyroid nodules with high-risk characteristics. Their study is published in Computerized Medical Imaging and Graphics.